"phase-iii-trials"

Bharat Biotech's 'pre-submission' meeting with the World Health Organization (WHO) will take on Wednesday for the approval for Covaxin.

The clinical trials will be performed on more than 2,400 subjects suffering from mild to moderate Covid-19, across over 40 sites in India

Natco Pharma had recently received approval from the Drug Controller General of India (DCGI) to conduct phase III clinical trials of Molnupiravir

The drug regulator gave nod for conducting the trial on mild and moderate Covid-19 patients

The phase III clinical study to be conducted in 15 sites across India will evaluate the immunogenicity and safety of the SARS-CoV-2 Covid-19 vaccine for protection against the disease

He had offered to be the first volunteer for the third phase trial of Covaxin, which started in the state today.

The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR

SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.